ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 755423 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 755423; 2) Community: the network communities that were significantly associated with the response to NSC 755423; 3) Molecule: the relationships between components within communities and NSC 755423; 4) MDR: the compounds that were significantly associated with the NSC 755423.

NSC Compound Enrichment Correlation
NSC 727049 11-(6'-Aminohexylidene]-5,6-dihydro-5-keto-2,3-dimethoxy-6-m ethyl-8,9-methylenedioxy-11H-indeno[1,2-c]isoquinoline 0.000778243021198128 0.52838181
NSC 746087 1-(7-Fluoro-3-methyl-quinoxalin-2-yl)-3-(3,4,5-trimethoxy-phenyl)-propenone 0.000778243021198128 0.47304362
NSC 763587 Null 0.000779967423316725 0.4963508
NSC 101003 Null 0.000779967423316734 0.42034434
NSC 174121 Methotrexate Derivative 0.000779967423316734 0.58191061
NSC 112846 N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid 0.000871592241209859 0.63209737
NSC 128687 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) 0.000871592241209859 0.38395349
NSC 301477 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-4-O-methyl-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- 0.000871592241209859 0.53002044
NSC 633497 Null 0.000871592241209859 0.08448328
NSC 635958 Null 0.000871592241209859 0.56054266
Total:157  Current:10    [First] [Prev] [Next] [Last]